Phenotype/Genotype Relationship in Left Ventricular Noncompaction: Ion Channel Gene Mutations Are Associated With Preserved Left Ventricular Systolic Function and Biventricular Noncompaction: Phenotype/Genotype of Noncompaction

Authors: Cambon-Viala, Marie, Gerard, Hilla, Nguyen, Karine, Richard, Pascale, Ader, Flavie, Pruny, Jean-François, Donal, Erwan, Eicher, Jean-Christophe, Huttin, Olivier, Selton-Suty, Christine, Raud-Raynier, Pascale, Jondeau, Guillaume, Mansencal, Nicolas, Sawka, Caroline, Casalta, Anne-Claire, Michel, Nicolas, Donghi, Valeria, Martel, Hélène, Faivre, Laurence, Charron, Philippe, Habib, Gilbert

Source: In Journal of Cardiac Failure June 2021 27(6):677-681

Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: a case study of the MOTIVATE trial.

Authors: Morisseau, Mathilde, Gomez-Roca, Carlos, Viala, Marie, Rabeau, Audrey, Loirat, Delphine, Munsch, Nadia, Thomas, Kristell, Pages, Cécile, Korakis, Iphigenie, Sibaud, Vincent, Delord, Jean-Pierre, Filleron, Thomas, Cabarrou, Bastien

Source: Investigational New Drugs; Dec2024, Vol. 42 Issue 6, p664-674, 11p

Subject Terms: STATISTICAL models, DRUG side effects, RESEARCH funding, PATIENT safety, CLINICAL trials, INVESTIGATIONAL drugs, PROBABILITY theory, ONCOLOGY, DESCRIPTIVE statistics, CANCER patients, IMMUNE checkpoint inhibitors, LONGITUDINAL method, METASTASIS, TUMORS, LUNG cancer, TIME

Left-ventricular non-compaction–comparison between different techniques of quantification of trabeculations: Should the diagnostic thresholds be modified?

Alternate Title: Non-compaction du ventricule gauche: Comparaison des différentes techniques de quantification des trabéculations. Devons-nous modifier les critères diagnostiques? (French)

Authors: Donghi, Valeria, Tradi, Farouk, Carbone, Andreina, Viala, Marie, Gaubert, Guillaume, Nguyen, Karine, Reant, Patricia, Donal, Erwan, Eicher, Jean-Christophe, Selton-Suty, Christine, Huttin, Olivier, Resseguier, Noemie, Michel, Nicolas, Guazzi, Marco, Jacquier, Alexis, Habib, Gilbert ^*

Source: In Archives of Cardiovascular Diseases May 2020 113(5):321-331

Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer

Authors: Chiba, Akiko, Raman, Rachna, Thomas, Alexandra, Lamy, Pierre-Jean, Viala, Marie, Pouderoux, Stephane, Mott, Sarah L., Schroeder, Mary C., Thezenas, Simon, Jacot, William

Source: In Clinical Breast Cancer April 2018 18(2):144-149

Ressources et richesses compensatoires chez des patients souffrant de troubles neuro-cérébraux.

Alternate Title: Compensatory remedies and resources in patients suffering from neurological brain disorders.

Authors: Viala, Marie-Françoise¹ (AUTHOR) vialafm@gmail.com

Source: Perspectives Psychiatriques. avr-jui2024, Vol. 63 Issue 2, p131-136. 6p.

Subject Terms: *PSYCHOLOGICAL tests, *LONG-term health care, *NEUROLOGICAL disorders, *PATIENT care, *RESONANCE

Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative Study.

Authors: Thomas, Quentin Dominique, Chaabouni, Mohamed, Al herk, Anas, Lefevbre, Cesar, Cavaillon, Sarah, Sinoquet, Léa, Pouderoux, Stéphane, Viala, Marie, Roca, Lise, Quantin, Xavier

Source: Cancers; Mar2024, Vol. 16 Issue 5, p992, 12p

Subject Terms: THERAPEUTIC use of antineoplastic agents, THERAPEUTIC use of monoclonal antibodies, PATIENT safety, DRUG side effects, TERMINATION of treatment, IMMUNOTHERAPY, CARBOPLATIN, RETROSPECTIVE studies, DESCRIPTIVE statistics, IMMUNE system, LONGITUDINAL method, CANCER chemotherapy, MONOCLONAL antibodies, DRUG efficacy, MEDICAL records, ACQUISITION of data, LUNG cancer, PACLITAXEL, TUMOR classification, PROGRESSION-free survival, COMPARATIVE studies, CONFIDENCE intervals, OVERALL survival, TOXICITY testing, EVALUATION, OLD age

Les TKI de 3e génération dans le cancer pulmonaire non à petites cellules EGFR muté ayant acquis une résistance secondaire T790M

Alternate Title: 3rd generation's TKI in lung cancer non-small cell EGFR-mutated having acquired a secondary T790M resistance (English)

Authors: Brosseau, Solenn, Viala, Marie, Varga, Andréa, Planchard, David, Besse, Benjamin, Soria, Jean-Charles

Source: In Bulletin du Cancer September 2015 102(9):749-757

Inhibiteurs de ALK de 2e génération dans le cancer bronchique non à petites cellules : revue de la littérature

Alternate Title: Second generation ALK inhibitors in non-small cell lung cancer: Systemic review (English)

Authors: Viala, Marie, Brosseau, Solenn, Planchard, David, Besse, Benjamin, Soria, Jean-Charles

Source: In Bulletin du Cancer April 2015 102(4):381-389

Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer.

Authors: Viala, Marie¹ (AUTHOR) marie.viala@icm.unicancer.fr, Firmin, Nelly^1,2 (AUTHOR), Touraine, Célia³ (AUTHOR), Pouderoux, Stéphane¹ (AUTHOR), Metge, Manon⁴ (AUTHOR), Rifai, Lobna⁵ (AUTHOR), Romieu, Gilles¹ (AUTHOR), de Forges, Hélène⁶ (AUTHOR), Roca, Lise³ (AUTHOR), Guiu, Séverine^1,2 (AUTHOR), D'Hondt, Véronique^1,2 (AUTHOR), Jacot, William^1,2 (AUTHOR)

Source: BMC Cancer. 7/15/2021, Vol. 21 Issue 1, p1-11. 11p.

Subject Terms: *VITAMIN D metabolism, *ADJUVANT chemotherapy, *CANCER chemotherapy, *CALCIUM metabolism, *BREAST cancer, *BREAST tumors, *DISEASE complications

Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer.

Authors: Eslami-S, Zahra, Cortés-Hernández, Luis Enrique, Sinoquet, Léa, Gauthier, Ludovic, Vautrot, Valentin, Cayrefourcq, Laure, Avoscan, Laure, Jacot, William, Pouderoux, Stéphane, Viala, Marie, Thomas, Quentin Dominique, Lamy, Pierre-Jean, Quantin, Xavier, Gobbo, Jessica, Alix-Panabières, Catherine

Source: British Journal of Cancer; Jan2024, Vol. 130 Issue 1, p63-72, 10p

Valeur péjorative des variations de poids en cours de chimiothérapie dans le cancer du sein non métastatique : causes, mécanismes impliqués et stratégies préventives

Alternate Title: Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms involved and preventive strategies (English)

Authors: Gadéa, Émilie, Thivat, Émilie, Wang-Lopez, Qian, Viala, Marie, Paulon, Rodolphe, Planchat, Éloïse, Chadeyras, Jean-Baptiste, Merlin, Charles, Coudert, Bruno, Bignon, Yves-Jean, Morio, Béatrice, Durando, Xavier

Source: In Bulletin du Cancer September 2013 100(9):865-870

Therapeutic Bayesian monitoring of sunitinib in two patients with impaired absorption or elimination.

Authors: Leenhardt, Fanny^1,2,3 fanny.leenhardt@icm.unicancer.fr, Viala, Marie⁴, Tosi, Diego^3,4, Samalin‐Scalzi, Emmanuelle⁴, Evrard, Alexandre^2,3,5, Mbatchi, Litaty C.^2,3,5

Source: Journal of Clinical Pharmacy & Therapeutics. Aug2021, Vol. 46 Issue 4, p1182-1184. 3p.

Subject Terms: *MALABSORPTION syndromes, *GASTRECTOMY, *INTESTINAL absorption, *DRUG monitoring, *HEMODIALYSIS, *STATISTICAL models, *COMORBIDITY

Comedications with Immune Checkpoint Inhibitors: Involvement of the Microbiota, Impact on Efficacy and Practical Implications.

Authors: Colard-Thomas, Julien, Thomas, Quentin Dominique, Viala, Marie

Source: Cancers; Apr2023, Vol. 15 Issue 8, p2276, 31p

Subject Terms: ANTIBIOTICS, IMMUNE checkpoint inhibitors, ADRENOCORTICAL hormones, GUT microbiome, IMMUNE system, PROTON pump inhibitors, IMMUNOTHERAPY, PHARMACODYNAMICS

Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study.

Authors: Viala, Marie¹ marie.viala@icm.unicancer.fr, Chiba, Akiko² achiba@wakehealth.edu, Thezenas, Simon³ simon.thezenas@icm.unicancer.fr, Delmond, Laure⁴ laure.delmond@icm.unicancer.fr, Lamy, Pierre-Jean⁵ pierre-jean.lamy@labosud-ocbiologie.fr, Mott, Sarah L.⁶ sarah-mott@uiowa.edu, Schroeder, Mary C.⁷ mary-schroeder@uiowa.edu, Thomas, Alexandra⁸ althomas@wakehealth.edu, Jacot, William¹ william.jacot@icm.unicancer.fr

Source: BMC Cancer. 7/30/2018, Vol. 18 Issue 1, p1-11. 11p. 7 Charts, 6 Graphs.

Subject Terms: *VITAMIN D in human nutrition, *PHYSIOLOGICAL effects of chemotherapy, *BREAST cancer treatment, *VITAMIN D deficiency, *HER2 protein, *HORMONE receptors

Impact des Thérapies Complémentaires sur la Survie de Patients Atteints d'un Cancer Traités par Chimiothérapie Orale dans un Établissement Hospitalier Français Spécialisé en Oncologie: Étude Exploratoire. (French)

Alternate Title: Impact of Complementary Medicines on Survival in Patients with Cancer Treated with Oral Chemotherapy in an Oncology Hospital in France: Exploratory Study. (English)

Authors: Ninot, Grégory, Guerdoux, Estelle, Carbonnel, François, Faravel, Kerstin, Ismael, Ludovic, Leenhardt, Fanny, Lognos, Béatrice, Perrier, Caroline, Philibert, Laurent, Tronc, Boris, Viala, Marie

Source: Oncologie (Tech Science Press); 2022, Vol. 24 Issue 4, p605-612, 8p

Subject Terms: ORAL drug administration, FRENCH people, ALTERNATIVE medicine, LOG-rank test, OVERALL survival, PROSTATE cancer

Geographic Terms: UNITED States

Oral targeted therapy dose adaptation in older patients with cancer: A real‐life French cohort.

Authors: Carbasse, Clément, Leenhardt, Fanny, Jacot, William, Perrier, Caroline, Pinguet, Frederic, Viala, Marie

Source: British Journal of Clinical Pharmacology; Jul2022, Vol. 88 Issue 7, p3370-3377, 8p

Subject Terms: CANCER patients, OLDER people, SUNITINIB, OLDER patients, AFATINIB, SORAFENIB

Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects.

Authors: Leenhardt, Fanny, Fiteni, Frédéric, Gauthier, Ludovic, Alexandre, Marie, Guiu, Séverine, Firmin, Nelly, Pouderoux, Stéphane, Viala, Marie, Lossaint, Gerald, Gautier, Chloé, Mollevi, Caroline, Gracia, Matthieu, Gongora, Celine, Mbatchi, Litaty, Evrard, Alexandre, Jacot, William

Source: Pharmaceutics; Apr2022, Vol. 14 Issue 4, pN.PAG-N.PAG, 12p

Subject Terms: METASTATIC breast cancer, DRUG interactions, DRUG monitoring, PHARMACOKINETICS, CANCER patients, ERIBULIN

Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer.

Authors: Sinoquet, Léa, Jacot, William, Gauthier, Ludovic, Pouderoux, Stéphane, Viala, Marie, Cayrefourcq, Laure, Quantin, Xavier, Alix-Panabières, Catherine

Source: Clinical Chemistry; Nov2021, Vol. 67 Issue 11, p1503-1512, 10p

Modernizing adverse events analysis in oncology clinical trials using alternative approaches: rationale and design of the MOTIVATE trial.

Authors: Cabarrou, Bastien, Gomez-Roca, Carlos, Viala, Marie, Rabeau, Audrey, Paulon, Rodolphe, Loirat, Delphine, Munsch, Nadia, Delord, Jean-Pierre, Filleron, Thomas

Source: Investigational New Drugs; Dec2020, Vol. 38 Issue 6, p1879-1887, 9p

Subject Terms: CLINICAL trials, DRUG toxicity, EXPERIMENTAL design, IMMUNOTHERAPY, ONCOLOGY, PATIENT safety, TREATMENT duration, ADVERSE health care events

Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer.

Authors: Jacot, William, Mazel, Martine, Mollevi, Caroline, Pouderoux, Stéphane, D’Hondt, Véronique, Cayrefourcq, Laure, Bourgier, Céline, Boissiere-Michot, Florence, Berrabah, Fella, Lopez-Crapez, Evelyne, Bidard, François-Clément, Viala, Marie, Maudelonde, Thierry, Guiu, Séverine, Alix-Panabières, Catherine

Source: Clinical Chemistry; Aug2020, Vol. 66 Issue 8, p1093-1101, 9p